1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Biologics Development
  6.  » Catalent’s Chair and CEO Shares His Views About Drug Development and Manufacturing in a Pandemic

Catalent’s Chair and CEO Shares His Views About Drug Development and Manufacturing in a Pandemic

Summary: In December 2021, John Chiminski was featured on the expert panel of STAT’s “A Look Ahead at Biotech in 2022” event, which focused on the ongoing battle against the SARS-CoV-2 virus and explored what might be in store for the biotech industry in the years to come.​

Click here to view the webinar